Bioproduktas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 311,937 | 463,552 | 606,601 | 712,022 | 657,748 | 779,919 | 993,262 | 1,309,141 |
| Profit before tax | 16,042 | 1,830 | 577 | -267 | 1,015 | 4,130 | 3,345 | 50,436 |
| Net profit | 13,501 | 1,477 | 353 | -374 | 71 | 3,475 | 2,167 | 42,272 |
| Equity | 87,837 | 122,838 | 102,783 | 102,409 | 102,480 | 105,955 | 108,122 | 150,394 |
| Liabilities | - | - | - | - | 302,417 | 226,184 | 351,150 | 123,725 |
| Non-current assets | 43,197 | 198,697 | 165,124 | 131,097 | 93,128 | 54,476 | 11,671 | 8,497 |
| Current assets | 139,676 | 221,517 | 169,437 | 265,366 | 340,101 | 292,588 | 448,774 | 265,356 |
| Total assets | 182,873 | 420,214 | 334,561 | 396,463 | 433,229 | 347,064 | 460,445 | 273,853 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 3,852 | 25,416 | 21,444 |
| Social insurance contributions | - | - | - | - | - | 15,963 | 21,030 | 20,525 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +26.0% | +48.6% | +30.9% | +17.4% | -7.6% | +18.6% | +27.4% | +31.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.4% | 0.4% | 0.1% | -0.1% | 0.0% | 1.0% | 0.5% | 15.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 15.4% | 1.2% | 0.3% | -0.4% | 0.1% | 3.3% | 2.0% | 28.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.3% | 0.3% | 0.1% | -0.1% | 0.0% | 0.4% | 0.2% | 3.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.1% | 0.4% | 0.1% | 0.0% | 0.2% | 0.5% | 0.3% | 3.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 3.0 | 2.1 | 3.2 | 0.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 87,053 | 83,025 | 101,100 | 89,003 | 97,444 | 179,983 | 195,397 | 296,407 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioproduktas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-23 | 997.38 |
| 2026-07-16 | 2026-07-17 | 997.38 |
| 2026-02-18 | 2026-03-01 | 0.38 |
| 2026-01-22 | 2026-02-05 | 0.38 |
| 2024-05-16 | 2024-05-19 | 2126.74 |
| 2024-05-15 | 2024-05-15 | 525.33 |
| 2024-04-16 | 2024-04-16 | 1309.39 |
Bioproduktas - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Bioproduktas is: 3 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 3.4 |
| 2025-03-17 | 2025-03-17 | 1498.43 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.